
    
      This is an 8-week double-blind, randomized, vehicle-controlled, multicenter study of NAFT-900
      compared to vehicle in the treatment of tinea capitis in children ≥6 years to <13 years of
      age.

      There will be approximately 60 subjects enrolled. Qualifying subjects with clinical evidence
      of a tinea capitis infection involving ≤ 15% of the scalp, confirmed by positive culture,
      will be randomized 2:1 to one of the following treatments:

        -  NAFT-900 (Naftifine hydrochloride foam, 3%)

        -  Vehicle Foam The study will consist of up to 6 visits. Subjects will apply the assigned
           study product twice daily to the affected area(s) for 4 weeks
    
  